These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25735954)

  • 1. IFNγ Induces DNA Methylation-Silenced GPR109A Expression via pSTAT1/p300 and H3K18 Acetylation in Colon Cancer.
    Bardhan K; Paschall AV; Yang D; Chen MR; Simon PS; Bhutia YD; Martin PM; Thangaraju M; Browning DD; Ganapathy V; Heaton CM; Gu K; Lee JR; Liu K
    Cancer Immunol Res; 2015 Jul; 3(7):795-805. PubMed ID: 25735954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon.
    Thangaraju M; Cresci GA; Liu K; Ananth S; Gnanaprakasam JP; Browning DD; Mellinger JD; Smith SB; Digby GJ; Lambert NA; Prasad PD; Ganapathy V
    Cancer Res; 2009 Apr; 69(7):2826-32. PubMed ID: 19276343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NF-κB p65 and p50 homodimer cooperate with IRF8 to activate iNOS transcription.
    Simon PS; Sharman SK; Lu C; Yang D; Paschall AV; Tulachan SS; Liu K
    BMC Cancer; 2015 Oct; 15():770. PubMed ID: 26497740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation represses IFN-gamma-induced and signal transducer and activator of transcription 1-mediated IFN regulatory factor 8 activation in colon carcinoma cells.
    McGough JM; Yang D; Huang S; Georgi D; Hewitt SM; Röcken C; Tänzer M; Ebert MP; Liu K
    Mol Cancer Res; 2008 Dec; 6(12):1841-51. PubMed ID: 19074829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival.
    Elangovan S; Pathania R; Ramachandran S; Ananth S; Padia RN; Lan L; Singh N; Martin PM; Hawthorn L; Prasad PD; Ganapathy V; Thangaraju M
    Cancer Res; 2014 Feb; 74(4):1166-78. PubMed ID: 24371223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis.
    Singh N; Gurav A; Sivaprakasam S; Brady E; Padia R; Shi H; Thangaraju M; Prasad PD; Manicassamy S; Munn DH; Lee JR; Offermanns S; Ganapathy V
    Immunity; 2014 Jan; 40(1):128-39. PubMed ID: 24412617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms.
    Felizardo RJF; de Almeida DC; Pereira RL; Watanabe IKM; Doimo NTS; Ribeiro WR; Cenedeze MA; Hiyane MI; Amano MT; Braga TT; Ferreira CM; Parmigiani RB; Andrade-Oliveira V; Volpini RA; Vinolo MAR; Mariño E; Robert R; Mackay CR; Camara NOS
    FASEB J; 2019 Nov; 33(11):11894-11908. PubMed ID: 31366236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colonic gene expression in conventional and germ-free mice with a focus on the butyrate receptor GPR109A and the butyrate transporter SLC5A8.
    Cresci GA; Thangaraju M; Mellinger JD; Liu K; Ganapathy V
    J Gastrointest Surg; 2010 Mar; 14(3):449-61. PubMed ID: 20033346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPR109A Expression in the Murine Min6 Pancreatic Beta Cell Line, and Its Relation with Glucose Metabolism and Inflammation.
    Yang S; Li X; Wang N; Yin G; Ma S; Fu Y; Wei C; Chen Y; Xu W
    Ann Clin Lab Sci; 2015; 45(3):315-22. PubMed ID: 26116596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of DNA methyltransferase-mediated gene silencing, anchorage-independent growth, and migration of colon cancer cells by interleukin-6.
    Foran E; Garrity-Park MM; Mureau C; Newell J; Smyrk TC; Limburg PJ; Egan LJ
    Mol Cancer Res; 2010 Apr; 8(4):471-81. PubMed ID: 20354000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bipartite butyrate-responsive element in the human calretinin (CALB2) promoter acts as a repressor in colon carcinoma cells but not in mesothelioma cells.
    Häner K; Henzi T; Pfefferli M; Künzli E; Salicio V; Schwaller B
    J Cell Biochem; 2010 Feb; 109(3):519-31. PubMed ID: 19998412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT3 NH2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen.
    Ray S; Boldogh I; Brasier AR
    Gastroenterology; 2005 Nov; 129(5):1616-32. PubMed ID: 16285960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of interleukin 1-induced matrix metalloproteinase 13 expression in human chondrocytes by interferon gamma.
    Ahmad R; Qureshi HY; El Mabrouk M; Sylvester J; Ahmad M; Zafarullah M
    Ann Rheum Dis; 2007 Jun; 66(6):782-9. PubMed ID: 17179173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FHL1 on chromosome X is a single-hit gastrointestinal tumor-suppressor gene and contributes to the formation of an epigenetic field defect.
    Asada K; Ando T; Niwa T; Nanjo S; Watanabe N; Okochi-Takada E; Yoshida T; Miyamoto K; Enomoto S; Ichinose M; Tsukamoto T; Ito S; Tatematsu M; Sugiyama T; Ushijima T
    Oncogene; 2013 Apr; 32(17):2140-9. PubMed ID: 22689052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Langerhans cells release prostaglandin D2 in response to nicotinic acid.
    Maciejewski-Lenoir D; Richman JG; Hakak Y; Gaidarov I; Behan DP; Connolly DT
    J Invest Dermatol; 2006 Dec; 126(12):2637-46. PubMed ID: 17008871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct modulation of IFNγ-induced transcription by BET bromodomain and catalytic P300/CBP inhibition in breast cancer.
    Hogg SJ; Motorna O; Kearney CJ; Derrick EB; House IG; Todorovski I; Kelly MJ; Zethoven M; Bromberg KD; Lai A; Beavis PA; Shortt J; Johnstone RW; Vervoort SJ
    Clin Epigenetics; 2022 Jul; 14(1):96. PubMed ID: 35902886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Niacin stimulates adiponectin secretion through the GPR109A receptor.
    Plaisance EP; Lukasova M; Offermanns S; Zhang Y; Cao G; Judd RL
    Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E549-58. PubMed ID: 19141678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 33 Signaling Restrains Sporadic Colon Cancer in an Interferon-γ-Dependent Manner.
    Eissmann MF; Dijkstra C; Wouters MA; Baloyan D; Mouradov D; Nguyen PM; Davalos-Salas M; Putoczki TL; Sieber OM; Mariadason JM; Ernst M; Masson F
    Cancer Immunol Res; 2018 Apr; 6(4):409-421. PubMed ID: 29463593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells.
    Lu C; Redd PS; Lee JR; Savage N; Liu K
    Oncoimmunology; 2016; 5(12):e1247135. PubMed ID: 28123883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y; Fatima N; Dufau ML
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.